Browsing "1. Journal Papers" by Identifier : ANNALS OF ONCOLOGY, Vol.33(2) : 181-192, 2022-02

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 1 of 1

This table browses all dspace content
Issue DateTitleJournal Title
2022A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trialANNALS OF ONCOLOGY
1

Browse

Links